TRT, explained: what testosterone replacement actually does, and who it’s for

Testosterone replacement therapy is a real, prescription-only medical treatment for men whose bodies cannot make enough testosterone because of a genuine fault in the testicles, pituitary or brain. It is not an anti-ageing tonic, a strength booster, or a lifestyle upgrade for healthy men with a number on the low side. The gap between what TRT is medically approved to treat and what some clinics are selling is wide, and the risks live in that gap.

This is informational coverage, not medical advice. If any of this is relevant to you, the answer is always the same: see a qualified doctor and get proper bloodwork.

What testosterone actually does — and how it changes with age

Testosterone's established jobs in the body are unglamorous and specific. It drives libido and sperm production, builds muscle size and strength, maintains bone density, supports red blood cell production, and influences how the body distributes fat. That is the real list.

The popular idea that testosterone makes men aggressive or badly behaved is largely a myth. The evidence ties the hormone to sexual, muscular, skeletal and blood-cell function, not to a personality.

Levels do fall with age, but slowly. After roughly age 40, testosterone drifts down by about 1–2% per year. That is a gradual slope, not the abrupt cliff of menopause. A slow, age-related decline is a normal part of getting older, not automatically a disease that needs correcting.

What clinically diagnosed hypogonadism is — and how it is actually diagnosed

Hypogonadism is the medical condition of having genuinely deficient testosterone. The key word is "and": diagnosis requires low testosterone plus consistent symptoms of testosterone deficiency. A low number on its own is not a diagnosis.

Clinicians generally treat a total testosterone below 300 ng/dL as low, against a normal adult male range of roughly 300–1,000 ng/dL. But the number only counts in context with symptoms, and it has to be confirmed properly.

Confirmation means two separate early-morning blood tests, taken roughly between 7 and 10 AM, when testosterone naturally peaks. Levels swing through the day, so timing matters. This is also why a single low reading can badly mislead you: in about 30% of cases where a first test reads low, the level comes back normal on a repeat test. Guidelines insist on confirming before anyone starts therapy for exactly this reason.

Bottom line

A diagnosis needs symptoms plus repeated low morning bloodwork, not one number from one blood draw. Roughly a third of first-low readings normalise on retest.

What legitimate, prescribed TRT is for — and what it is not

Approved TRT treats pathological hypogonadism: low testosterone caused by an identifiable problem with the testicles, the pituitary, or the brain. That is the condition it exists for, and it is prescription-only and doctor-supervised by design.

What testosterone is not approved for is just as important. Boosting testosterone is not FDA-approved to improve strength, athletic performance, physical appearance, or to treat or prevent the ordinary problems of normal ageing. The FDA has concluded the evidence does not support testosterone therapy for "age-related hypogonadism" — no testosterone product is approved for low testosterone due solely to getting older. After a 2014–15 label clarification, direct-to-consumer "Low T" advertising in the US was curtailed for this reason.

So if the pitch is about feeling younger, leaner or stronger rather than treating a diagnosed condition, it is describing a use the regulator has specifically declined to endorse.

The 'low-T clinic' and anti-ageing pitch: where marketing diverges from medicine

The medicine is narrow and cautious. A lot of the marketing is broad and eager. That divergence is the thing to watch.

Real treatment starts from a confirmed diagnosis and a cause. A lifestyle pitch starts from a symptom list almost anyone could nod along to — low energy, low drive, a softer midsection — and works backwards to a prescription.

Red flags that a clinic is selling testosterone as a product rather than treating a condition:

It frames TRT as anti-ageing, performance enhancement, or a route to a better physique — none of which are approved uses.
It is ready to prescribe off a single blood test, or off symptoms alone, without repeated confirmed morning bloodwork.
It treats a normal age-related decline as a disease requiring correction.
It is light on the trade-offs below — fertility, monitoring, the lifelong commitment — because those complicate the sale.

The real risks and trade-offs, part one: fertility, atrophy, blood and pressure

Exogenous testosterone shuts down the body's own production by suppressing the hypothalamic-pituitary-gonadal axis. The practical consequence is that sperm production falls — counts can drop toward zero — and the testicles can shrink. Testosterone is effectively a male contraceptive. It should not be used by men trying to conceive. Recovery of fertility after stopping typically takes months and is not guaranteed in every man.

TRT also commonly raises red blood cell count, a condition called polycythaemia or erythrocytosis. Thicker blood is a real concern, and it is one of the main reasons therapy requires ongoing blood monitoring rather than a set-and-forget prescription.

There is also a newer warning. On 28 February 2025 the FDA made class-wide labeling changes to testosterone products and added a warning that testosterone can raise blood pressure, based on required post-market monitoring studies.

The real risks and trade-offs, part two: the heart debate, dependence and the lifelong commitment

The cardiovascular picture is the one most often oversimplified. In 2023, the large TRAVERSE trial — over 5,000 middle-aged and older men with hypogonadism who already had, or were at high risk of, cardiovascular disease — found testosterone gel was non-inferior to placebo for major adverse cardiac events (7.0% vs 7.3%). On the strength of that, the FDA removed the old boxed cardiovascular-risk warning in February 2025.

But "no increase in major cardiac events" is not the same as "no risks". In the same trial, the testosterone group had more atrial fibrillation (3.5% vs 2.4%), more acute kidney injury (2.3% vs 1.5%) and more pulmonary embolism (0.9% vs 0.5%). The reassurance also came specifically from older men with diagnosed hypogonadism — not from healthy men chasing higher numbers. And the FDA added the new blood-pressure warning at the same moment it dropped the old one.

Removing the heart warning does not mean testosterone is proven safe for everyone — the trial that prompted it also flagged more atrial fibrillation, kidney injury and clots.

Because TRT suppresses your own production while you take it, for men whose underlying cause is not reversible it is generally a lifelong treatment. Stopping can bring symptoms back as the body slowly restarts. That means lifelong: regular doctor visits, repeat blood tests, and monitoring aimed at keeping levels in the normal range — not pushing them as high as possible. Higher is not better; overshooting the normal range adds risk (thicker blood, raised pressure) without proven added benefit.

Testosterone is also contraindicated in men with known or suspected prostate or breast cancer, and is cautioned against in those with a recent heart attack or stroke, untreated severe sleep apnoea, high red-cell counts, a history of blood clots, or near-term fertility plans.

The bottom line

If you have real symptoms and you are worried about your testosterone, the right move is not a clinic that promises a younger you. It is a qualified doctor and proper, repeated morning bloodwork that either confirms a genuine condition or rules it out.

This article is informational coverage, not medical advice, and it is not a how-to. It contains no dosing, protocols or instructions for obtaining a prescription drug — testosterone is prescription-only and should be used only under medical supervision. For anything specific to your situation, consult a qualified clinician.

Sources

The Catalyst Feed

Content TeamIndependent, hands-on coverage of health, fitness & the tech that tracks it. Reviews you can trust — no hype.

#trt #testosterone #hypogonadism #mens-health #prescription-drugs #hormones #fertility